Edition:
United Kingdom

China Medical System Holdings Ltd (0867.HK)

0867.HK on Hong Kong Stock

16.54HKD
15 Feb 2018
Change (% chg)

HK$0.34 (+2.10%)
Prev Close
HK$16.20
Open
HK$16.30
Day's High
HK$16.54
Day's Low
HK$16.04
Volume
982,567
Avg. Vol
4,107,496
52-wk High
HK$19.96
52-wk Low
HK$12.22

Summary

Name Age Since Current Position

Kong Lam

52 Executive Chairman of the Board, Chief Executive Officer, President

Yanling Chen

46 2006 Chief Financial Officer, Vice President, Executive Director

Hongbing Chen

50 2006 Chief Operating Officer, Vice President, Executive Director

Wai Ming Wong

56 2010 Chief Technical Officer

Sanyan Wu

35 2017 Company Secretary

Kam Shing Cheung

54 2010 Independent Non-Executive Director

Chong Shun Leung

52 2017 Non-Executive Independent Director

Chi Keung Wu

60 2010 Independent Non-Executive Director

Biographies

Name Description

Kong Lam

Mr. Lam Kong serves as Executive Chairman of the Board, Chief Executive Officer, President of China Medical System Holdings Limited. He was appointed as an executive Director, on 18 December 2006. He acquired Shenzhen Kangzhe Pharmaceutical Co., Ltd. (“Shenzhen Kangzhe”) through his company over 20 years ago, building the business from a small company engaged in trading of pharmaceutical products to a leading pharmaceutical service company providing marketing, promotion and sale services. Mr. Lam is responsible for the creation, implementation and management of the Group’s development and growth strategy and the management of the overall operation of the Group. Mr. Lam possesses clinical experience and has nearly 21 years of experience in marketing, promotion, sale and other value-added services for pharmaceutical products in China. He received his bachelor’s degree in medicine from Zhanjiang Medical College in 1986, the name of which was changed to Guangdong Medical College in 1992. Mr. Lam is a member of the Nomination Committee of the Company and sole director of Treasure Sea Limited, one of the controlling shareholders of the Company.

Yanling Chen

Ms. Chen Yanling serves as Chief Financial Officer, Vice President, Executive Director of China Medical System Holdings Limited. She was appointed as an executive Director on 18 December 2006. She joined the Group in 1995 and has remained with the Group since then. Ms. Chen is responsible for the Group’s financial management, investor relations affairs and office administration. She received EMBA from the International East-West University and is a senior accountant. Ms. Chen was awarded the Top Place of 2016 “All-Asia Best CFO (Overall) in Healthcare and Pharmaceutical Industry” 2016 by the Institutional Investor magazine in July 2016. She earned the honour for the fifth time consecutively.

Hongbing Chen

Mr. Chen Hongbing serves as Chief Operating Officer, Vice President, Executive Director of China Medical System Holdings Limited. Mr. Chen was appointed as an executive Director on 18 December 2006. He joined the Group in 1995 and has remained with the Group since then. Mr. Chen is responsible for the operation of the Group’s marketing, promotion and sale business and management of product manufacture. He had acquired about 4 years’ clinical experience as a resident doctor with Nanjing Gulou Hospital from 1990 to 1994 prior to joining the Group in 1995. He graduated from Nanjing Medical College with a bachelor’s degree in clinical medicine in 1990.

Wai Ming Wong

Dr. Wong Wai Ming serves as Chief Technical Officer of China Medical System Holdings Limited since 2010. He first joined the Group in 2000 and then became the Chief R&D Officer in 2007. He is responsible for dealing with technical issues in introducing products and providing technical advice to the Group for selecting pharmaceutical products. Prior to this, Dr. Wong worked as manager of China pharma department for Jebsen Co. Ltd. He studied bio-chemistry and received his bachelor’s degree in science and PhD from the University of Hong Kong in 1983 and 1993, respectively.

Sanyan Wu

Ms. Wu Sanyan is the Company Secretary of the Company. Ms. Wu joined the Group in 2009 and currently serves as Director of the Legal Department. Ms. Wu is primarily responsible for overseeing the legal and regulatory compliance matters of the Group (including compliance with the Listing Rules). The responsibilities of Ms. Wu since her joining of the Group include advising on compliance of laws and regulations applicable to the Group(including the Listing Rules). Considering that Ms. Wu is familiar with the Group matters and has extensive experience in compliance matters, the Board believes Ms. Wu is a qualified candidate for the position of company secretary. Ms. Wu has obtained a double bachelor’s degree in history and law in 2004, and a master’s degree in international law in 2008, both from the Wuhan University.

Kam Shing Cheung

Mr. Cheung Kam Shing (Terry) serves as Independent Non-Executive Director of China Medical System Holdings Limited. He was appointed as an independent non-executive Director of the Company on 18 August 2010. Mr. Cheung has more than 20 years’ experience in securities broking, investment banking, fund management, private equity and other financial areas. The companies he worked for after graduating from the University of Hong Kong in 1984 included Sanyo Securities (Asia) Limited, Fidelity International Investment Management Limited, Kerry Securities Limited, Sassoon Securities Limited, and Core-Pacific Yamaichi International (HK) Limited from 1984 to 2000. Mr. Cheung served as Managing Director at Culturecom Holdings Limited (a company listed on the Stock Exchange with stock code 0343) from 2000 to 2005. He later served as Managing Director of Nouveau Investment Group Limited from 2005 to mid 2010. He served as the Chief Operating Officer of Greater China Professional Services Limited, being a professional services company providing corporate governance, asset valuation, and other corporate advisory services, since July 2010, and stopped acting as the Chief Operating Officer of Greater China Professional Services Limited since 18 March 2015. Mr. Cheung was an independent non-executive director of Greens Holdings Limited (a company listed on the Stock Exchange with stock code 1318) from 22 December 2014 to 14 March 2015, stopped acting as the independent non-executive director of Greens Holdings Limited since 14 March 2015 and was appointed as the executive director of Greens Holdings Limited on the same day. Mr. Cheung received his bachelor’s degree in social sciences from the University of Hong Kong in 1984 and his master’s degree in science (financial economics) from the University of London in 1995.

Chong Shun Leung

Mr. Leung Chong Shun is Non-Executive Independent Director of the Company. Mr. Leung became a practicing lawyer since 1991 and was the Chief Representative of Woo Kwan Lee & Lo Beijing Office. He is currently a Partner of Woo Kwan Lee & Lo. Mr. Leung is familiar with corporate finance, M&A and IPO legal services and has been involved in various listing and acquisition transactions of Chinese H Share companies and red chip companies. Mr. Leung is currently an Attesting Officer appointed by the PRC. Mr. Leung was an independent non-executive director of China Communications Construction Company Limited (HKEX stock code: 01800) from January 2011 to November 2017. He is currently an independent non-executive director of SSY Group Limited (formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd., HKEX stock code: 02005), China National Materials Company Limited (HKEX stock code: 01893) and China Coal Energy Company Limited (HKEX stock code: 01898). Mr. Leung graduated from the University of Hong Kong in 1988 and obtained a bachelor’s degree in laws with honors. He is qualified as a solicitor in Hong Kong and England.

Chi Keung Wu

Mr. Wu Chi Keung (Edward), CPA, serves as an Independent Non-Executive Director of China Medical System Holdings Limited., since June 25, 2010. Mr. Wu has more than 30 years of experience in financial audit and specializes in providing auditing and assurance services, financial due diligence reviews, support services for merger and acquisitions, corporate restructuring and fund raising engagements. Mr. Wu was a partner of Deloitte Touche Tohmatsu until he retired in December 2008. Mr. Wu is currently the managing Director of a family-owned private company engaging in property and other investment activities. He is also an independent non-executive Director of Jinchuan Group International Resources Co., Ltd (stock code: 2362), Zhong Fa Zhan Holdings Limited (stock code: 475), Huabao International Holdings Ltd. (stock code: 336) and YuanShengTai Dairy Farm Ltd. (stock code: 1431), all the shares of which are listed on the Stock Exchange. Mr. Wu was also an independent non-executive Director of JF Household Furnishings Limited (stock code: 776) from 16 August 2011 to 5 October 2012, an independent non-executive director of Greater China Professional Services Limited (stock code: 8193) from 18 May 2011 to 2 July 2014, an independent non-executive director of China Renji Medical Group Limited (stock code: 648) from 3 January 2012 to 15 July 2014, and an independent non-executive director of Link Holdings Limited (stock code: 8237) from 20 June 2014 to 3 October 2014. Mr. Wu is an associate of Hong Kong Institute of Certified Public Accountants and a fellow of Association of Chartered Certified Accountants in the United Kingdom. Mr. Wu graduated from Hong Kong Polytechnic (now known as Hong Kong Polytechnic University) in 1980 with a high diploma in accountancy.

Basic Compensation

Name Fiscal Year Total

Kong Lam

796,000

Yanling Chen

730,000

Hongbing Chen

859,000

Wai Ming Wong

--

Sanyan Wu

--

Kam Shing Cheung

156,000

Chong Shun Leung

--

Chi Keung Wu

156,000
As Of  31 Dec 2016